BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6223203)

  • 1. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
    Gati WP; Knaus EE; Wiebe LI
    Mol Pharmacol; 1983 Jan; 23(1):146-52. PubMed ID: 6223203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane permeation characteristics of 5'-modified thymidine analogs.
    Domin BA; Mahony WB; Koszalka GW; Porter DJ; Hajian G; Zimmerman TP
    Mol Pharmacol; 1992 May; 41(5):950-6. PubMed ID: 1588925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective transport of thymidine by cultured cells resistant to 5-bromodeoxyuridine.
    Lynch TP; Cass CE; Paterson AR
    J Supramol Struct; 1977; 6(3):363-74. PubMed ID: 145516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modifications at the 2'- and 3'-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter.
    Gati WP; Misra HK; Knaus EE; Wiebe LI
    Biochem Pharmacol; 1984 Nov; 33(21):3325-31. PubMed ID: 6497896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antiviral and cytotoxic activity of 2'-deoxyuridines, 2'-fluoro-2'-deoxyuridines and 2'-arabinouridines containing 5-(1-hydroxy-2-halo-2-ethoxycarbonylethyl)-, 5-(1-hydroxy-2-iodo-2- carboxyethyl)- and 5-[1-hydroxy (or methoxy)-2-iodoethyl] substituents.
    Kumar R; Wiebe LI; Knaus EE; Allen TM; Tempest ML
    Drug Des Discov; 1992 Feb; 8(3):179-89. PubMed ID: 1326340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of 5-(2,2-difluorocyclopropyl)-2'-deoxyuridine deoxyuridine diastereomers.
    Tandon M; Singh S; Xu L; Kumar P; Wiebe LI; Knaus EE; Gati WP; Tempest ML
    Drug Des Discov; 1992; 9(1):79-91. PubMed ID: 1333829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of membrane transport of 5-fluoro[6-3H]deoxyuridine into L5178Y mouse leukemia cells.
    Wigler PW; Schluter DN
    Cancer Res; 1976 Sep; 36(9 pt.1):3207-11. PubMed ID: 135641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus.
    Smee DF; Humphreys DE; Hurst BL; Barnard DL
    Antivir Chem Chemother; 2008; 19(1):15-24. PubMed ID: 18610554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thymidine transport by 3'-azido-3'-deoxythymidine and its metabolites.
    Zimmerman TP; Domin BA; Mahony WB
    Oncol Res; 1993; 5(12):483-7. PubMed ID: 8086670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney.
    Gutierrez MM; Giacomini KM
    Biochim Biophys Acta; 1993 Jul; 1149(2):202-8. PubMed ID: 8323939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 5-bromodeoxyuridine on interferon production in human cells.
    Baker PN; Bradshaw TK; Morser J; Burke DC
    J Gen Virol; 1979 Oct; 45(1):177-84. PubMed ID: 160442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
    Cheng YC; Dutschman G; De Clercq E; Jones AS; Rahim SG; Verhelst G; Walker RT
    Mol Pharmacol; 1981 Jul; 20(1):230-3. PubMed ID: 6270535
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2.
    Lunato AJ; Wang J; Woollard JE; Anisuzzaman AK; Ji W; Rong FG; Ikeda S; Soloway AH; Eriksson S; Ives DH; Blue TE; Tjarks W
    J Med Chem; 1999 Aug; 42(17):3378-89. PubMed ID: 10464024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Iodo-2-deoxyuridine resistance of vaccinia viruses in cells endowed with thymidine kinase activity.
    Marcialis MA; Biondi E; Atzeni A; Schivo ML; Uccheddu P; Loddo B
    Experientia; 1973 Jun; 29(6):733-4. PubMed ID: 4268858
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by nucleosides of glucose-transport activity in human erythrocytes.
    Jarvis SM
    Biochem J; 1988 Jan; 249(2):383-9. PubMed ID: 3342020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
    de Clercq E; Verhelst G; Descamps J; Bergstrom DE
    Acta Microbiol Acad Sci Hung; 1981; 28(3):307-12. PubMed ID: 6272553
    [No Abstract]   [Full Text] [Related]  

  • 17. Highly selective drug combinations for human colon cancer cells resistant in vitro to 5-fluoro-2'-deoxyuridine.
    Sobrero AF; Handschumacher RE; Bertino JR
    Cancer Res; 1985 Jul; 45(7):3161-3. PubMed ID: 3159475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
    Mathews CK
    Exp Cell Res; 1975 Apr; 92(1):39-46. PubMed ID: 124255
    [No Abstract]   [Full Text] [Related]  

  • 19. Relaxed enantioselectivity of human mitochondrial thymidine kinase and chemotherapeutic uses of L-nucleoside analogues.
    Verri A; Priori G; Spadari S; Tondelli L; Focher F
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):317-20. PubMed ID: 9359870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
    Lang TT; Young JD; Cass CE
    Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.